/TTRX

TTRX Stock - Turn Therapeutics Inc.

Q: What is the analyst price target for TTRX?

Analyst price target information is not currently available for TTRX.

Q: What is TTRX's market cap?

Market capitalization information is not currently available for TTRX.

Healthcare|Biotechnology|NASDAQ

$3.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $3.30

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for TTRX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.00

52W High$26.50

52W Low$2.57

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023
Revenue	N/A	N/A
Gross Profit	N/A	N/A
Gross Margin	N/A	N/A
Operating Income	$-1,797,124	$-2,308,149
Net Income	$-1,768,415	$-2,292,267
Net Margin	N/A	N/A
EPS	$0.00	$0.00

Company Overview

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Visit Website

Frequently Asked Questions about TTRX

What is TTRX's current stock price?

Turn Therapeutics Inc. (TTRX) is currently trading at $3.00 per share. The stock has moved +0.00% today.

What is the analyst price target for TTRX?

No analyst price targets are currently available for this stock.

What sector is Turn Therapeutics Inc. in?

Turn Therapeutics Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is TTRX's market cap?

Turn Therapeutics Inc. has a market capitalization of $0.09 billion, making it a small-cap company.

Does TTRX pay dividends?

No, Turn Therapeutics Inc. does not currently pay a dividend to shareholders.